Literature DB >> 16248884

8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid stimulates GABA release from interneurons projecting to CA1 pyramidal neurons in the rat hippocampus via pre-synaptic alpha7 acetylcholine receptors.

Takeshi Kanno1, Takahiro Yaguchi, Satoshi Yamamoto, Hideyuki Yamamoto, Hirokazu Fujikawa, Tetsu Nagata, Akito Tanaka, Tomoyuki Nishizaki.   

Abstract

Nicotinic acetylcholine (ACh) receptors, such as alpha7, alpha3beta4 and alpha4beta2 receptors in the hippocampus, are suggested to modulate neurotransmitter release. 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA) (100 nM), a linoleic acid derivative, potentiated responses of alpha7, alpha3beta4 and alpha4beta2 ACh receptors expressed in Xenopus oocytes that are blocked by 3-(1-[dimethylaminopropyl] indol-3-yl)-4-[indol-3-yl] maleimide (GF109203X), a selective inhibitor of protein kinase C (PKC), except for alpha3beta4 ACh receptors. DCP-LA enhanced the nicotine-triggered release of GABA from rat hippocampal slices in the presence of tetrodotoxin in a bell-shaped dose-dependent manner at concentrations ranging from 10 nM to 10 microM, although DCP-LA by itself had no effect on GABA release. The DCP-LA action was inhibited by GF109203X or alpha-bungarotoxin, an inhibitor of alpha7 ACh receptors, but not by mecamylamine or dihydro-beta-erithroidine, an inhibitor of alpha3beta4 and alpha4beta2 ACh receptors. A similar effect on GABA release was obtained with 12-O-tetradecanoylphorbol 13-acetate, a PKC activator. DCP-LA (100 nM) also enhanced GABA release triggered by choline, an agonist of alpha7 ACh receptors, but not 3-[2(s)-azetidinylmethoxy] pyridine, an agonist of alpha4beta2 ACh receptors. In addition, DCP-LA (100 nM) increased the rate of nicotine-triggered GABA(A) receptor-mediated miniature inhibitory post-synaptic currents, monitored from CA1 pyramidal neurons of rat hippocampal slices, and the effect was also inhibited by GF109203X or alpha-bungarotoxin but not by mecamylamine. Thus, the results of the present study indicate that DCP-LA stimulates GABA release by enhancing activity of pre-synaptic alpha7 ACh receptors present on the GABAergic terminals of interneurons that transmit to CA1 pyramidal neurons via a PKC pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248884     DOI: 10.1111/j.1471-4159.2005.03398.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  N-Ethylmaleimide Dissociates α7 ACh Receptor from a Complex with NSF and Promotes Its Delivery to the Presynaptic Membrane.

Authors:  Tomoyuki Nishizaki
Journal:  Neurochem Res       Date:  2016-04-23       Impact factor: 3.996

2.  Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by α7 nicotinic receptor agonist.

Authors:  Sridhar T Narla; Ilona Klejbor; Barbara Birkaya; Yu-Wei Lee; Janusz Morys; Ewa K Stachowiak; Dorota Prokop; Merouane Bencherif; Michal K Stachowiak
Journal:  Stem Cells Transl Med       Date:  2013-09-06       Impact factor: 6.940

3.  Free fatty acid derivative HUHS2002 potentiates α7 ACh receptor responses through indirect activation of CaMKII.

Authors:  Takeshi Kanno; Tadashi Shimizu; Akito Tanaka; Takaaki Nishimoto; Tomoyuki Nishizaki
Journal:  Lipids       Date:  2012-07-21       Impact factor: 1.880

4.  Linoleic acid derivative DCP-LA ameliorates stress-induced depression-related behavior by promoting cell surface 5-HT1A receptor translocation, stimulating serotonin release, and inactivating GSK-3β.

Authors:  Takeshi Kanno; Akito Tanaka; Tomoyuki Nishizaki
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

5.  8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration.

Authors:  Takeshi Kanno; Takahiro Yaguchi; Tadashi Shimizu; Akito Tanaka; Tomoyuki Nishizaki
Journal:  Lipids       Date:  2012-05-15       Impact factor: 1.880

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.